pharmaceutical investing OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights
pharmaceutical investing OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
EraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR